Clinical Trials Directory

Trials / Completed

CompletedNCT06353074

Uterine Preservation With Acar's Atony Suture for Postpartum Uterine Hemorrhage

Uterine Preservation With Acar's Atony Suture for Postpartum Uterine Atony

Status
Completed
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
Necmettin Erbakan University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers

Summary

This study is aimed to show effectiveness of a new suture technique to stop postpartum uterine bleeding due to uterine atony.

Detailed description

A retrospective study of all women received Acar's uterine compressive atony suture between January 2021-November 2023 at a single tertiary hospital with approximately 4000 deliveries per year, was performed. The local protocol for PPH due to uterine atony is uterine manual compression, 20 IU of intravenous oxytocin in 500 cc of normal saline at 500 cc/h; 800 µg of misoprostol inserted per rectal. If additional treatment is needed, carbetocin 100mcg in 100 cc of normal saline or tranexamic acid in different posologies are used. If uterine atony persists, intrauterine balloon tamponade or uterine compressive sutures were applied at the discretion of the physician and according to mode of delivery. When uterine compressive suture was performed, original Acar's atony suture was applied.

Conditions

Timeline

Start date
2021-01-01
Primary completion
2023-11-30
Completion
2023-11-30
First posted
2024-04-08
Last updated
2024-04-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06353074. Inclusion in this directory is not an endorsement.

Uterine Preservation With Acar's Atony Suture for Postpartum Uterine Hemorrhage (NCT06353074) · Clinical Trials Directory